Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis [Phase 3]

View source ↗

Summary

Phase 3 clinical study comparing Indinol Forto 200 mg capsules with Visanne 2 mg tablets for the treatment of endometriosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indinol Forto 200 mg capsules
  • Visanne 2 mg tablets (dienogest)

Snippet

Sponsor: Alcea | Conditions: Endometriosis | Phase 3 | Status: RECRUITING